Key facts
- SensEarly’s last known valuation is $7.0M (Mar 2025).
- It has raised $1.7M across 1 recorded rounds; the latest was Seed Round ($1.7M) in Feb 2025.
- SensEarly has filed 1 Form D with the SEC, most recently Mar 2025 ($1.7M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for SensEarly
Funding rounds
1 roundsAbout SensEarly
Operator of an AI-powered care management platform intended to predict and prevent chronic organ failure. The company's platform leverages advanced AI algorithms and sensors to monitor liver and kidney health in real-time, offering early detection and intervention for patients at risk of organ failure, enabling healthcare providers to reduce hospitalizations and improve patient outcomes through personalized care and predictive insights.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2024
- Employees
- 3
- Website
- sensearly.ai/
- Ownership
- Privately Held (backing)
SensEarly doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SensEarly shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SensEarly in its N-PORT filings yet. We sweep new filings monthly.